Marc Israel | White & Case LLP International Law Firm, Global Law Practice
Marc Israel
Marc Israel

Marc Israel

Partner, London

T +44 20 7532 1137

E [email protected]

Overview

Marc is a partner in the Firm's Global Antitrust Practice. He has considerable experience in a wide range of antitrust work and has been involved in some of the most high-profile UK and European cases in recent years in the fields of M&A, cartels and antitrust litigation.

Much of Marc's work involves dealing with cross-border cases (both for UK and overseas clients) and he regularly represents clients before the UK and European competition authorities, and has also appeared before the UK and European courts in competition cases.

Marc is recommended in the Global Competition Review 100.

Bars and Courts

  • England and Wales

Education

  • Legal Practice Course, The College of Law, London
  • Common Professional Examination, The College of Law, London
  • Master of Arts, University of Cambridge
  • Modern & Medieval Languages, St. John's College, University of Cambridge

Languages

  • English
  • French

Experience

Highlighted cases, some of which established legal precedents now reflected in guidance published by the relevant antitrust agencies, include the following:

Deutsche Bank and Goldman Sachs on their joint acquisition of the private equity portfolio of the National Bank of Greece.

BATS Global Markets Inc. on its acquisition of Chi-X to create the largest pan-European equities trading platform, which was cleared unconditionally by the UK's competition authorities following an in-depth review.

Mitsubishi Rayon Company on its acquisition of Lucite, one of the first mergers cleared by MOFCOM in China based on behavioural remedies.

IBA Health on the ground-breaking IBA Health Limited v OFT case before both the Competition Appeal Tribunal and the Court of Appeal. This was the first successful appeal of a merger clearance decision under the Enterprise Act, a decision that continues to have wide-ranging implications for UK merger control procedure and the way in which the UK authorities have approached subsequent cases.

Pinewood Healthcare on its successful claim for damages against Reckitt Benkiser for abusing its dominant position in the supply of Gaviscon.

GB eye on the investigation by the UK's Competition & Markets Authority into price-fixing of goods sold online, a case which led to the UK's first ever director disqualification for breaches of antitrust law.

A major international financial institution on the first antitrust investigation conducted by the UK's Financial Conduct Authority.

A major European financial institution in connection with the European Commission's investigation into alleged cartel infringements in the foreign exchange sector.

A major international financial institution on the market investigation by the UK's Financial Conduct Authority into the asset management industry.